A comparison of fulvestrant plus a targeted agent with fulvestrant alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: a meta-analysis

DOI: 10.2147/OTT.S166653

Keywords: fulvestrant, breast cancer, combination therapy, endocrine resistance

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text